FDA Questioned About Plans To Investigate GSK For Hiding Cancer Risk from Zantac
A House lawmaker is asking FDA whether it plans to investigate GlaxoSmithKline for potentially hiding cancer risks from Zantac for decades in order to maintain profits.
Tag Archives: GlaxoSmithKline
-
-
Potential Risk of Cancer from Zantac Known By Drug Maker For Decades: Report
An investigative report indicates GlaxoSmithKline knew Zantac could transform into NDMA, a known cancer-causing chemical, since the drug was first developed, but never told the FDA.
-
Court Consolidates 40 Zantac Lawsuits Pending in New York State for Pretrial Litigation
Dozens of Zantac lawsuits filed in New York state courts have been consolidated for pretrial proceedings over claims the recalled heartburn drug may cause cancer.
-
Trial Court Dismissal of Zofran Birth Defect Lawsuits Upheld on Appeal Before First Circuit
The dismissal of hundreds of Zofran birth defect lawsuits was upheld by a federal appeals court which determined GlaxoSmithKline did not have the authority to change the drug's label warnings.
-
Zantac Lawsuit Filed By Dozens of Plaintiffs in Delaware State Court After Federal MDL Dismissed
Despite dismissal of federal Zantac lawsuits, plaintiffs continue to file claims in state courts.
-
MDL Judge Dismisses Zantac Litigation, After Excluding Expert Testimony on Cancer Risk
A judge has ordered all federal Zantac lawsuits dismissed after questioning the science behind claims that the recalled heartburn drug is linked to an increased risk of cancer.
-
GSK Removes Blenrep From U.S. Market, Due Poor Clinical Trial Performance for Multiple Myeloma Drug
The multiple myeloma drug Blenrep is being removed from the U.S. market after the fast-tracked cancer drug failed to perform in a recent clinical trial.
-
Zantac Study Finding Increased Risk of Cancer Results in Supplemental Expert Reports Being Filed in MDL
Plaintiffs involved in Zantac litigation have submitted new evidence from a recently published study which links Zantac use to four different types of cancer.
-
Lawsuits Over Zantac Cancers Not Supported in Federal MDL Being Filed in State Courts
State courts are being flooded with thousands of lawsuits over Zantac cancers which have not been included in the consolidated federal Multidistrict Litigation.
-
Court To Evaluate Expert Testimony Linking Side Effects Zantac and Cancer Next Week
Daubert hearings for expert witnesses slated for Zantac cancer trials will begin on September 21.
